Lexaria Bioscience (LEXX) Operating Leases (2020 - 2026)
Lexaria Bioscience (LEXX) posted Operating Leases of $53,679 for fiscal Q3 2026 (quarter ended May 31, 2026), down 38.1% from $86,714 a year earlier and down 13.9% from the prior quarter.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Operating Leases (2020 - 2026) Analysis & Trends
At the end of FY2025 (ended Aug 31, 2025), Lexaria Bioscience's Operating Leases came in at $78,903, down 27.8% from FY2024.
- Annual Operating Leases shows a five-year compound annual growth rate of -2.5% (FY2020 to FY2025).
- In prior fiscal years, Lexaria Bioscience's Operating Leases was $109,319 in FY2024 and $49,989 in FY2021 (-44.1%).
- The fiscal Q3 2026 figure stands as the lowest quarterly Operating Leases since fiscal Q3 2022.
- On a year-over-year basis, Operating Leases has declined in each of the last four quarters, with an average decline of 32.6% over the last four quarters.
- According to Business Quant data, Operating Leases for the three prior fiscal quarters was $62,326 (Q2 2026), $70,819 (Q1 2026) and $78,903 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Lexaria Bioscience | 3.39 Mn | -12.26 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 53,679.00 |
| Feb 28, 2026 | 62,326.00 |
| Nov 30, 2025 | 70,819.00 |
| Aug 31, 2025 | 78,903.00 |
| May 31, 2025 | 86,714.00 |
| Feb 28, 2025 | 94,386.00 |
| Nov 30, 2024 | 101,920.00 |
| Aug 31, 2024 | 109,319.00 |
| May 31, 2022 | 18,339.00 |
| Feb 28, 2022 | 29,080.00 |
| Aug 31, 2021 | 49,989.00 |
| May 31, 2021 | 60,164.00 |
| Feb 28, 2021 | 70,156.00 |
| Nov 30, 2020 | 79,969.00 |
| Aug 31, 2020 | 89,393.00 |
API Access
Lexaria Bioscience Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();